ARS Pharmaceuticals, Inc. - Common Stock SPRY 深 滬
已收盤 09-06 16:00:00 美东时间
11.36
-0.390
-3.32%
華盛通- 最 高11.76
- 今 開11.76
- 成交量 109.75万股
- 最 低 11.00
- 昨 收 11.75
- 總市值 10.91亿
- 52周最高 16.50
- 市盈率 靜 --
- 換手率 1.14%
- 52周最低 2.55
- 委 比 71.99%
- 總股本 9599.73万
- 歷史最高 63.41
- 量 比 1.09
- 振 幅 6.47%
- 歷史最低 2.55
- 每 手 1
- 風險率 2.69%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | ARS制药公司：Leerink Partners将目标价从$20提高至$21
ARS Pharmaceuticals Inc : Leerink Partners Raises Target Price to $21 From $20
08-27 12:09
Looking Into ARS Pharmaceuticals's Recent Short Interest
ARS Pharmaceuticals's (NYSE:SPRY) short percent of float has risen 13.47% since...
08-20 01:30
美股牛股 | 绩后飙涨24%！星巴克迎来“天降猛男”？来福威食品单日暴涨48%
绩后飙涨24%！星巴克“换帅”获华尔街集体看好！ESOA单日暴涨37%，第三财季盈利增长逾5倍>>
08-14 19:10
Lexicon to cut 50% of workforce to focus on sotagliflozin
Lexicon Pharmaceuticals (NASDAQ:LXRX) plans to cut around 50% of its workforce, or more than 75 jobs, to prioritize commercialization of its drug sotagliflozin, also known as Inpefa and Zynquista. The...
08-13 22:17
快讯 | ARS Pharmaceuticals Inc：雷蒙德詹姆斯将目标价从18美元上调至22美元.
ARS Pharmaceuticals Inc : Raymond James Raises Target Price to $22 From $18
08-13 19:20
快讯 | ARS制药公司：雷蒙德詹姆斯将评级升至强烈买入。
ARS Pharmaceuticals Inc : Raymond James Raises to Strong Buy From Outperform
08-13 19:19
Raymond James Upgrades ARS Pharmaceuticals to Strong Buy, Raises Price Target to $22
Raymond James analyst Ryan Deschner upgrades ARS Pharmaceuticals (NASDAQ:SPRY) from Outperform to Strong Buy and raises the price target from $18 to $22.
08-13 17:35
ARS Pharmaceuticals’ Neffy Aims for Global Market Impact
An announcement from ARS Pharmaceuticals (SPRY) is now available. ARS Pharmaceu...
08-13 09:17
快讯 | ARS制药公司高管称预计今年晚些时候在欧洲推出Neffy
ARS Pharmaceuticals Exec Says Expect to Make Neffy Available in Europe Later Th...
08-12 20:19
快讯 | ARS制药公司高管表示，预计在2024年第三季度提交美国关于Neffy 1毫克剂量的补充营销申请。-电话会议
ARS Pharmaceuticals Exec Says Expect to File Supplemental Marketing Application...
08-12 20:17
